Cannlabs Inc
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consu… Read more
Market Cap & Net Worth: Cannlabs Inc (CANL)
Cannlabs Inc (PINK:CANL) has a market capitalization of $46.32K ($46.32K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51503 globally and #16186 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cannlabs Inc's stock price $0.00 by its total outstanding shares 463164704 (463.16 Million).
Cannlabs Inc Market Cap History: 2015 to 2025
Cannlabs Inc's market capitalization history from 2015 to 2025. Data shows change from $55.63 Million to $46.32K (-60.57% CAGR).
Cannlabs Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cannlabs Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.84x
Cannlabs Inc's market cap is 0.84 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
4.26x
Cannlabs Inc's market cap is 4.26 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $111.16 Million | $1.36 Million | -$1.58 Million | 81.45x | N/A |
| 2017 | $115.79 Million | $1.36 Million | -$1.58 Million | 84.84x | N/A |
| 2018 | $48.63 Million | $1.36 Million | -$1.58 Million | 35.63x | N/A |
| 2019 | $23.25 Million | $2.50 Million | $803.58K | 9.31x | 28.93x |
| 2020 | $24.08 Million | $2.77 Million | $520.57K | 8.71x | 46.27x |
| 2021 | $15.28 Million | $3.18 Million | $712.80K | 4.80x | 21.44x |
| 2022 | $3.71 Million | $4.39 Million | $869.17K | 0.84x | 4.26x |
Competitor Companies of CANL by Market Capitalization
Companies near Cannlabs Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Cannlabs Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Cannlabs Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Cannlabs Inc's market cap moved from $55.63 Million to $ 46.32K, with a yearly change of -60.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $46.32K | 0.00% |
| 2024 | $46.32K | -90.91% |
| 2023 | $509.48K | -86.25% |
| 2022 | $3.71 Million | -75.76% |
| 2021 | $15.28 Million | -36.54% |
| 2020 | $24.08 Million | +3.59% |
| 2019 | $23.25 Million | -52.19% |
| 2018 | $48.63 Million | -58.00% |
| 2017 | $115.79 Million | +4.17% |
| 2016 | $111.16 Million | +99.83% |
| 2015 | $55.63 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cannlabs Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $46.32K USD |
| MoneyControl | $46.32K USD |
| MarketWatch | $46.32K USD |
| marketcap.company | $46.32K USD |
| Reuters | $46.32K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.